IV Synercid
November 1999
Rhone-Poulenc Rorer is now marketing IV Synercid.
It's the new antibiotic of "last resort"...for vancomycin-resistant Enterococcus faecium (VREF).
Synercid is actually a combination of two antibiotics...quinupristin and dalfopristin.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote